Aaron serves as our Chief Manufacturing Officer, having joined in 2023. He joins from TCR2 Therapeutics where he served as the VP, Manufacturing with responsibility for Manufacturing, Supply Chain, MSAT, and Patient Operations. Prior to that, Aaron was Vice President, Engineering & Supply Chain at Autolus, Inc., where he led the build out of their Global Supply Chain function, build of their Manufacturing network, and managed their internal Manufacturing at CGT Catapult in Stevenage, UK. Before that, he was VP, Global Supply Chain & Manufacturing at Sucampo Pharmaceuticals, where he was responsible for global supply of all commercial and clinical products.
In all, Aaron has over 20 years of experience within manufacturing, supply chain, business process development, organizational transformation, and facility design/construction at Johnson & Johnson, MedImmune, AstraZeneca, Sucampo, Autolus, TCR2 Therapeutics, and now Quell.
He holds a B.S. in Mechanical Engineering from the University of Pennsylvania, an M.S. in Mechanical Engineering from Rutgers, and an M.B.A. from University of Maryland – Global Campus.
In all, Aaron has over 20 years of experience within manufacturing, supply chain, business process development, organizational transformation, and facility design/construction at Johnson & Johnson, MedImmune, AstraZeneca, Sucampo, Autolus, TCR2 Therapeutics, and now Quell.
He holds a B.S. in Mechanical Engineering from the University of Pennsylvania, an M.S. in Mechanical Engineering from Rutgers, and an M.B.A. from University of Maryland – Global Campus.